FOLD logo

Amicus Therapeutics (FOLD) CAPEX

Annual CAPEX

$7.44 M
+$3.67 M+97.56%

December 31, 2023

Summary

Performance

1-Year Change

+97.56%

3-Year Change

+130.55%

5-Year Change

+17.95%

15-Year Change

+64.38%

FOLD CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.58%
FOLD annual capital expenditures is higher than 61.58% of companies in Healthcare sector

High & Low

All-time High

$20.01 M
FOLD annual capital expenditures is currently -62.82% below its historical high of $20.01 million

3-Year Low

$3.77 M
FOLD annual capital expenditures is currently +97.56% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FOLD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FOLD next annual earnings announcement is scheduled for Feb 28, 2025

OtherFOLDcash flowmetrics:

Annual FCF

-$76.53 M
FOLD annual free cash flow is -$76.53 million

Annual CFO

-$69.09 M
FOLD annual cash flow from operations is -$69.09 million

Annual CFI

$98.06 M
FOLD annual cash flow from investing activities is $98.06 million

Annual CFF

$61.68 M
FOLD annual cash flow from financing activities is $61.68 million

Quarterly CAPEX

$356.00 K
-$742.00 K-67.58%

September 30, 2024

Summary

Performance

3-Month Change

-67.58%

1-Year Change

-77.25%

3-Year Change

-77.25%

5-Year Change

-77.25%

FOLD Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.79%
FOLD quarterly capital expenditures is higher than 42.79% of companies in Healthcare sector

High & Low

All-time High

$10.93 M
FOLD quarterly capital expenditures is currently -96.74% below its historical high of $10.93 million

3-Year Low

-$137.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FOLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FOLD next earnings announcement is scheduled for Feb 28, 2025

OtherFOLDcash flowmetrics:

Quarterly FCF

-$23.33 M
FOLD quarterly free cash flow is -$23.33 million

Quarterly CFO

-$22.97 M
FOLD quarterly cash flow from operations is -$22.97 million

Quarterly CFI

$34.27 M
FOLD quarterly cash flow from investing activities is $34.27 million

Quarterly CFF

$18.19 M
FOLD quarterly cash flow from financing activities is $18.19 million

TTM CAPEX

$5.00 M
-$1.21 M-19.48%

September 30, 2024

Summary

Performance

3-Month Change

-19.48%

1-Year Change

-40.42%

3-Year Change

-40.42%

5-Year Change

-40.42%

FOLD TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.56%
FOLD TTM capital expenditures is higher than 54.56% of companies in Healthcare sector

High & Low

All-time High

$20.01 M
FOLD TTM capital expenditures is currently -75.03% below its historical high of $20.01 million

3-Year Low

$2.85 M
FOLD TTM capital expenditures is currently +75.36% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FOLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FOLD next earnings announcement is scheduled for Feb 28, 2025

OtherFOLDcash flowmetrics:

TTM FCF

-$31.51 M
FOLD TTM free cash flow is -$31.51 million

TTM CFO

-$26.52 M
FOLD TTM cash flow from operations is -$26.52 million

TTM CFI

-$4.13 M
FOLD TTM cash flow from investing activities is -$4.13 million

TTM CFF

$12.23 M
FOLD TTM cash flow from financing activities is $12.23 million

FOLD CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+97.6%-77.3%-40.4%
3 y3 years+130.6%-77.3%-40.4%
5 y5 years+17.9%-77.3%-40.4%

FOLD CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+97.6%-86.7%+359.9%-40.4%+75.4%
5 y5-year-62.8%+130.6%-96.7%+359.9%-75.0%+93.3%
alltimeall time-62.8%+3026.1%-96.7%+359.9%-75.0%+2983.9%

Amicus Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$356.00 K(-67.6%)
$5.00 M(-19.5%)
Jun 2024
-
$1.10 M(-39.4%)
$6.21 M(-15.1%)
Mar 2024
-
$1.81 M(+4.6%)
$7.31 M(-1.8%)
Dec 2023
$7.44 M(+97.6%)
$1.73 M(+10.6%)
$7.44 M(-11.3%)
Sep 2023
-
$1.56 M(-28.9%)
$8.39 M(+25.5%)
Jun 2023
-
$2.20 M(+13.4%)
$6.68 M(+38.2%)
Mar 2023
-
$1.94 M(-27.5%)
$4.84 M(+28.4%)
Dec 2022
$3.77 M(-3.0%)
$2.68 M(-2054.0%)
$3.77 M(+32.2%)
Sep 2022
-
-$137.00 K(-138.6%)
$2.85 M(-26.5%)
Jun 2022
-
$355.00 K(-59.2%)
$3.88 M(-0.3%)
Mar 2022
-
$871.00 K(-50.5%)
$3.89 M(+0.1%)
Dec 2021
$3.88 M(+20.4%)
$1.76 M(+97.8%)
$3.88 M(+21.7%)
Sep 2021
-
$890.00 K(+143.2%)
$3.19 M(+23.4%)
Jun 2021
-
$366.00 K(-57.8%)
$2.58 M(-21.4%)
Mar 2021
-
$868.00 K(-18.7%)
$3.29 M(+1.9%)
Dec 2020
$3.23 M(-83.9%)
$1.07 M(+275.7%)
$3.23 M(-75.3%)
Sep 2020
-
$284.00 K(-73.5%)
$13.09 M(-22.0%)
Jun 2020
-
$1.07 M(+32.8%)
$16.78 M(-6.1%)
Mar 2020
-
$806.00 K(-92.6%)
$17.87 M(-10.7%)
Dec 2019
$20.01 M(+217.2%)
$10.93 M(+174.7%)
$20.01 M(+84.9%)
Sep 2019
-
$3.98 M(+83.6%)
$10.82 M(+13.5%)
Jun 2019
-
$2.17 M(-26.4%)
$9.54 M(+13.1%)
Mar 2019
-
$2.94 M(+69.5%)
$8.43 M(+33.7%)
Dec 2018
$6.31 M(+39.4%)
$1.74 M(-35.4%)
$6.31 M(+10.7%)
Sep 2018
-
$2.69 M(+153.3%)
$5.70 M(+38.1%)
Jun 2018
-
$1.06 M(+29.7%)
$4.13 M(-10.5%)
Mar 2018
-
$819.00 K(-27.4%)
$4.61 M(+1.9%)
Dec 2017
$4.53 M(-23.9%)
$1.13 M(+0.8%)
$4.53 M(+18.2%)
Sep 2017
-
$1.12 M(-27.7%)
$3.83 M(+5.7%)
Jun 2017
-
$1.55 M(+111.3%)
$3.62 M(-4.8%)
Mar 2017
-
$732.00 K(+69.8%)
$3.81 M(-36.1%)
Dec 2016
$5.95 M
$431.00 K(-52.7%)
$5.95 M(-26.4%)
Sep 2016
-
$912.00 K(-47.3%)
$8.09 M(+1.2%)
Jun 2016
-
$1.73 M(-39.9%)
$8.00 M(+15.2%)
DateAnnualQuarterlyTTM
Mar 2016
-
$2.88 M(+11.9%)
$6.94 M(+44.1%)
Dec 2015
$4.82 M(+1923.9%)
$2.57 M(+214.7%)
$4.82 M(+110.2%)
Sep 2015
-
$817.00 K(+20.9%)
$2.29 M(+49.3%)
Jun 2015
-
$676.00 K(-10.2%)
$1.53 M(+61.4%)
Mar 2015
-
$753.00 K(+1537.0%)
$951.00 K(+299.6%)
Dec 2014
$238.00 K(-65.8%)
$46.00 K(-23.3%)
$238.00 K(-1.7%)
Sep 2014
-
$60.00 K(-34.8%)
$242.00 K(-4.0%)
Jun 2014
-
$92.00 K(+130.0%)
$252.00 K(-30.6%)
Mar 2014
-
$40.00 K(-20.0%)
$363.00 K(-47.8%)
Dec 2013
$695.00 K(-83.9%)
$50.00 K(-28.6%)
$695.00 K(-13.3%)
Sep 2013
-
$70.00 K(-65.5%)
$802.00 K(-16.5%)
Jun 2013
-
$203.00 K(-45.4%)
$960.00 K(-40.5%)
Mar 2013
-
$372.00 K(+136.9%)
$1.61 M(-62.7%)
Dec 2012
$4.32 M(+204.5%)
$157.00 K(-31.1%)
$4.32 M(-16.7%)
Sep 2012
-
$228.00 K(-73.4%)
$5.19 M(+0.2%)
Jun 2012
-
$857.00 K(-72.2%)
$5.18 M(+16.8%)
Mar 2012
-
$3.08 M(+201.6%)
$4.43 M(+212.0%)
Dec 2011
$1.42 M(+269.8%)
$1.02 M(+373.1%)
$1.42 M(+141.9%)
Sep 2011
-
$216.00 K(+94.6%)
$587.00 K(+36.2%)
Jun 2011
-
$111.00 K(+56.3%)
$431.00 K(+11.7%)
Mar 2011
-
$71.00 K(-62.4%)
$386.00 K(+0.5%)
Dec 2010
$384.00 K(-78.7%)
$189.00 K(+215.0%)
$384.00 K(+38.1%)
Sep 2010
-
$60.00 K(-9.1%)
$278.00 K(-44.6%)
Jun 2010
-
$66.00 K(-4.3%)
$502.00 K(-58.5%)
Mar 2010
-
$69.00 K(-16.9%)
$1.21 M(-33.0%)
Dec 2009
$1.81 M(-32.2%)
$83.00 K(-70.8%)
$1.81 M(-33.8%)
Sep 2009
-
$284.00 K(-63.4%)
$2.73 M(-10.5%)
Jun 2009
-
$775.00 K(+16.5%)
$3.05 M(-3.8%)
Mar 2009
-
$665.00 K(-33.8%)
$3.17 M(+18.9%)
Dec 2008
$2.67 M(+298.7%)
$1.00 M(+66.2%)
$2.67 M(+60.4%)
Sep 2008
-
$604.00 K(-32.7%)
$1.66 M(+57.0%)
Jun 2008
-
$897.00 K(+453.7%)
$1.06 M(+553.7%)
Mar 2008
-
$162.00 K
$162.00 K
Dec 2007
$669.00 K
-
-

FAQ

  • What is Amicus Therapeutics annual capital expenditures?
  • What is the all time high annual CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics annual CAPEX year-on-year change?
  • What is Amicus Therapeutics quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly CAPEX year-on-year change?
  • What is Amicus Therapeutics TTM capital expenditures?
  • What is the all time high TTM CAPEX for Amicus Therapeutics?
  • What is Amicus Therapeutics TTM CAPEX year-on-year change?

What is Amicus Therapeutics annual capital expenditures?

The current annual CAPEX of FOLD is $7.44 M

What is the all time high annual CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high annual capital expenditures is $20.01 M

What is Amicus Therapeutics annual CAPEX year-on-year change?

Over the past year, FOLD annual capital expenditures has changed by +$3.67 M (+97.56%)

What is Amicus Therapeutics quarterly capital expenditures?

The current quarterly CAPEX of FOLD is $356.00 K

What is the all time high quarterly CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly capital expenditures is $10.93 M

What is Amicus Therapeutics quarterly CAPEX year-on-year change?

Over the past year, FOLD quarterly capital expenditures has changed by -$1.21 M (-77.25%)

What is Amicus Therapeutics TTM capital expenditures?

The current TTM CAPEX of FOLD is $5.00 M

What is the all time high TTM CAPEX for Amicus Therapeutics?

Amicus Therapeutics all-time high TTM capital expenditures is $20.01 M

What is Amicus Therapeutics TTM CAPEX year-on-year change?

Over the past year, FOLD TTM capital expenditures has changed by -$3.39 M (-40.42%)